Penicillium marneffei infection in an immunocompromised traveler: A case report and literature review

Journal of Travel Medicine

Volumn 12, Issue 5, 2005, Pages 291-294

  Carey, Jeanne ^a   Hofflich, Heather ^a   Amre, Ramila ^a   Protic, John ^a   Perlman, David C ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CD4 ANTIGEN; COTRIMOXAZOLE; ITRACONAZOLE; TOBRAMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; BLOOD CULTURE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; FEVER; FOLLOW UP; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHADENOPATHY; MALE; MYCELIUM; MYCOSIS; NONHUMAN; OPPORTUNISTIC INFECTION; PATIENT COUNSELING; PENICILLIUM MARNEFFEI; REVIEW; TRAVEL; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 30444436908     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2005.12511     Document Type: Review

References (13)

1. Ranjana K, Pryokumar K, Singh T, et al. Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur State, India. J Infect 2002; 45:268-271.
2. Sirisanthana T, Supparatpinyo K. Epidemiology and management of penicilliosis in human immunodeficiency virus infected patients. Int J Infect Dis 1998; 3:48-53.
3. DiSalvo AF, Fickling AM, Ajello L. Infection caused by Penicillium marneffei: description of first natural infection in man. Am J Clin Pathol 1973; 60:259-263.
4. Duong TA. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clin Infect Dis 1996; 23:125-130.
5. Wortman PD. Infection with Penicillium marneffei. Int J Dermatol 1996; 35:393-399.
6. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41(RR-17):1-9.
7. Supparatpinyo K, Khamwan C, Baosoung V, et al. Disseminated Penicillium marneffei infection in Southeast Asia. Lancet 1994; 344:110-113.
8. Deng Z, Ribas JL, Gibson DW, Connor DH. Infections caused by Penicillium marneffei in China and Southeast Asia: review of eighteen published cases and report of four more Chinese cases. Rev Infect Dis 1998; 10:640-652.
9. Supparatpinyo K, Perriens J, Nelson E, Sirisanthana T. A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus. N Engl J Med 1998; 339:1739-1743.
10. Chariyalertsak S, Supparatpinyo K, Sirisanthana T, Nelson KE. A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand. Clin Infect Dis 2002; 34:277-284.
11. Radford SA, Johnson EM, Warnock DW. In vitro studies of activity of voriconazole (UK-109, 496), a new triazole antifungal agent, against emerging and less-common mold pathogens. Antimicrob Agents Chemother 1997; 41:841-843.
12. Piehl MR, Kaplan RL, Haber MH. Disseminated penicilliosis in a patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med 1988; 112:1262-1264.
13. Pautler KB, Padhye AA, Ajello L. Imported Penicilliosis marneffei in the United States: report of a second human infection. J Med Vet Mycol 1984; 22:433-438.